This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: sitagliptin

In brief

June 2015 Br J Cardiol 2015;22:61–2

In brief

BJCardio Staff

Abstract

Cholesterol lowering significantly reduces stroke in the elderly Use of cholesterol lowering drugs (statins and fibrates) is associated with a one third lower risk of stroke in older adults without previous disease, finds a study published in the BMJ. A research team based in France set out to determine the association between use of lipid-lowering drugs in healthy older people and long-term risk of coronary heart disease and stroke. They tracked 7,484 men and women (average age 74 years) with no known history of vascular events, such as heart attacks and strokes, living in three French cities (Bordeaux, Dijon and Montpellier). After an aver

| Full text
In brief

May 2012 Br J Cardiol 2012;19:58

In brief

BJCardio Staff

Abstract

This image of Tetralogy of Fallot has won Carol Young, a radiographer at Great Ormond Street Hospital, London, an award for the best image quality and lowest radiation dose in the Siemens Healthcare International CT Image Contest. She beat 627 other entries from 43 countries Sitagliptin licence in renal disease Sitagliptin (Januvia®, MSD) has received a licence in the UK for use in people with type 2 diabetes with moderate to severe renal impairment. The licence follows data from two clinical studies. In one study comparing sitagliptin (25 mg or 50 mg once daily) with glipizide (2.5 to 20 mg once daily) in patients with type 2 diabetes and

| Full text

For healthcare professionals only

Add Banner

Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now